Abstract
Purpose
Thyrotropin (TSH)-secreting pituitary adenoma (TSHoma) is a rare cause of TSH-dependent hyperthyroidism. The first therapeutic option is surgery. Medical treatment with somatostatin analogs is also effective. To obviate the need for lifelong drug therapy, gamma knife radiosurgery (GKRS) might be considered in selected patients. We report the largest series of patients with TSHoma treated by GKRS at a single center.
Methods
This study was a retrospective analysis of 18 consecutive patients with TSHoma treated by GKRS between 1994 and 2022. Normalization of hyperthyroidism, when present at the time of surgery, and control of tumor growth were the main outcomes of the study.
Results
The median follow-up after GKRS treatment was 114 months (IQR, 57–213 months; range 17–285 months). No patients had growth of the residual tumor after GKRS. Remission of hyperthyroidism occurred in 9 of the 11 (81.8%) patients who were hyperthyroid before GKRS. The probability of hyperthyroidism remission three years after GKRS was 59.1% (95% CI 27.9–90.3%). No major side effects occurred after GKRS. One patient out of the 15 patients (6.7%) with normal baseline adrenal function and follow-up longer than 3 years developed new onset hypoadrenalism, while hypogonadism did not occur in the 13 patients with baseline normal function.
Conclusion
Our study shows that GKRS is an effective and safe adjuvant treatment for selected patients with residual or recurring TSHoma. The option of GKRS as an alternative treatment to lifelong medical treatment with somatostatin analogs should be thoroughly discussed with the patients.
Similar content being viewed by others
References
Beck-Peccoz P, Brucker-Davis F, Persani L, Smallridge RC, Weintraub BD (1995) Thyrotropin-secreting pituitary tumors. Endocr Rev 17(6):610–638. https://doi.org/10.1210/edrv-17-6-610
Amlashi FG, Tritos NA (2016) Thyrotropin-secreting pituitary adenomas: epidemiology, diagnosis, and management. Endocrine 52(3):427–440. https://doi.org/10.1007/s12020-016-0863-3
Tjörnstrand A, Nyström HF (2017) Diagnosis of endocrine disease: diagnostic approach to TSH-producing pituitary adenoma. Eur J Endocrinol 177(4):R183–R197. https://doi.org/10.1530/EJE-16-1029
Beck-Peccoz P, Lania A, Beckers A, Chatterjee K, Wemeau JL (2013) European thyroid association guidelines for the diagnosis and treatment of thyrotropin-secreting pituitary tumors. Eur Thyroid J 2(2):76–82. https://doi.org/10.1159/000351007
Losa M, Giovanelli M, Persani L, Mortini P, Faglia G, Beck-Peccoz P (1996) Criteria of cure and follow-up of central hyperthyroidism due to thyrotropin-secreting pituitary adenomas. J Clin Endocrinol Metab 81(8):3086–3090. https://doi.org/10.1210/jcem.81.8.8768879
Brucker-Davis F, Oldfield EH, Skarulis MC, Doppman JL, Weintraub BD (1999) Thyrotropin secreting pituitary tumors: diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health. J Clin EndocrinolMetab 84(2):476–486. https://doi.org/10.1210/jcem.84.2.5505
Socin HV, Chanson P, Delemer B, Tabarin A, Rohmer V, Mockel J, Stevenaert A, Beckers A (2003) The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients. Eur J Endocrinol 148(4):433–442. https://doi.org/10.1530/eje.0.1480433
Ónnestam L, Berinder K, Burman P, Dahlqvist P, Engström BE, Wahlberg J, Nyström HF (2013) National incidence and prevalence of TSH secreting pituitary adenomas in Sweden. J Clin Endocrinol Metab 98(2):626–635. https://doi.org/10.1210/jc.2012-3362
Malchiodi E, Profka E, Ferrante E, Sala E, Verrua E, Campi I, Lania AG, Arosio M, Locatelli M, Mortini P, Losa M, Motti E, Beck-Peccoz P, Spada A, Mantovani G (2014) Thyrotropin-secreting pituitary adenomas: outcome of pituitary surgery and irradiation. J Clin Endocrinol Metab 99(6):2069–2076. https://doi.org/10.1210/jc.2013-4376
Chanson P, Weintraub BD, Harris AG (1993) Octreotide therapy for thyroid-stimulating hormone-secreting pituitary adenomas. A follow-up of 52 patients. Ann Intern Med 119(3):236–240. https://doi.org/10.7326/0003-4819-119-3-199308010-00010
Rimareix F, Grunenwald S, Vezzosi D, Riviere LD, Bennet A, Caron P (2015) Primary medical treatment of thyrotropin-secreting pituitary adenomas by first-generation somatostatin analogs: a case study of seven patients. Thyroid 25(8):877–882. https://doi.org/10.1089/thy.2015.0041
Fliers E, van Furth WR, Bisschop PH (2012) Cure of a thyrotrophin (TSH)-secreting pituitary adenoma by medical therapy. Clin Endocrinol (Oxf) 77(5):788–790
Albano L, Losa M, Barzaghi LR, Niranjan A, Siddiqui Z, Flickinger JC, Lunsford LD, Mortini P (2021) Gamma knife radiosurgery for pituitary tumors: a systematic review and meta-analysis. Cancers (Basel) 13(19):4998. https://doi.org/10.3390/cancers13194998
Losa M, Spatola G, Albano L, Gandolfi A, Del Vecchio A, Bolognesi A, Mortini P (2017) Frequency, pattern, and outcome of recurrences after gamma knife radiosurgery for pituitary adenomas. Endocrine 56(3):595–602. https://doi.org/10.1007/s12020-016-1081-8
Cozzi R, Lasio G, Cardia A, Felisati G, Montini M, Attanasio R (2009) Perioperative cortisol can predict hypothalamus-pituitary-adrenal status in clinically non-functioning pituitary adenomas. J Endocrinol Invest 32(5):460–464. https://doi.org/10.1007/BF03346486
Michaelidou M, Yadegarfar G, Morris L, Dolan S, Robinson A, Naseem A, Livingston M, Duff CJ, Trainer P, Fryer AA, Heald AH (2021) Recalibration of thinking about adrenocortical function assessment: how the “random” cortisol relates to the short synacthen test results. Cardiovasc Endocrinol Metab 10(2):137–145. https://doi.org/10.1097/XCE.0000000000000250
Ohki M, Sato K, Tuchiya D, Sato S, Saito S, Kinjo T, Kayama T, Jokura H, Yoshimoto T (1999) A case of TSH-secreting pituitary adenoma associated with an unruptured aneurysm: successful treatment by two stage operation and gamma-knife. No To Shinkei 51(10):895–899
Kon YC, Loh KC, Tambyah JA, Lim LH, Marshall JC (2001) Thyrotrophin (TSH)-secreting pituitary macroadenoma with cavernous sinus invasion. Singap Med J 42(9):433–437
Kasliwal M, Gupta A, Sharma M (2012) Single low dose adjuvant Gamma knife radiosurgery for thyrotropin secreting pituitary adenoma. Acta Neurochir (Wien) 154(4):665–666. https://doi.org/10.1007/s00701-012-1284-6
Mouslech Z, Somali M, Sakali AK, Savopoulos C, Mastorakos G, Hatzitolios AI (2016) TSH-secreting pituitary adenomas treated by gamma knife radiosurgery: our case experience and a review of the literature. Hormones (Athens) 15(1):122–128. https://doi.org/10.14310/horm.2002.1640
Losa M, Mortini P, Franzin A, Barzaghi R, Mandelli C, Giovanelli M (1999) Surgical management of thyrotropin secreting pituitary adenomas. Pituitary 2(2):127–131. https://doi.org/10.1023/a:1009987530852
Clarke MJ, Erickson D, Castro MR, Atkinson JLD (2008) Thyroid-stimulating hormone pituitary adenomas. J Neurosurg 109(1):17–22. https://doi.org/10.3171/JNS/2008/109/7/0017
Macchia E, Gasperi M, Lombardi M, Morselli L, Pinchera A, Acerbi G, Rossi G, Martino E (2009) Clinical aspects and therapeutic outcome in thyrotropin-secreting pituitary adenomas: a single center experience. J Endocrinol Invest 32(9):773–779. https://doi.org/10.1007/BF03346535
Zhao W, Ye H, Li Y, Zhou L, Lu B, Zhang S, Wen J, Li S, Yang Y, Hu R (2012) Thyrotropin-secreting pituitary adenomas: diagnosis and management of patients from one Chinese center. Wien Klin Wochenschr 124(19–20):678–684. https://doi.org/10.1007/s00508-012-0216-z
Byun J, Kim JH, Kim YH, Cho YH, Hong SH, Kim CJ (2020) Thyroid-stimulating hormone-secreting pituitary adenomas: single institutional experience of 14 consecutive cases. J Korean Neurosurg Soc 63(4):495–503. https://doi.org/10.3340/jkns.2019.0169
Mortini P, Barzaghi LR, Albano L, Panni P, Losa M (2018) Microsurgical therapy of pituitary adenomas. Endocrine 59(1):72–81. https://doi.org/10.1007/s12020-017-1458-3
Pomeraniec IJ, Dallapiazza RF, Xu Z, Jane J, Sheehan JP (2016) Early versus late Gamma Knife radiosurgery following transsphenoidal resection for nonfunctioning pituitary macroadenomas: a matched cohort study. J Neurosurg 125(1):202–212. https://doi.org/10.3171/2015.5.JNS15581
Sheehan JP, Starke RM, Mathieu D, Young B, Sneed PK, Chiang VL, Lee JY, Kano H, Park KJ, Niranjan A, Kondziolka D, Barnett GH, Rush S, Golfinos JG, Lunsford LD (2013) Gamma Knife radiosurgery for the management of nonfunctioning pituitary adenomas: a multicenter study. J Neurosurg 119(2):446–456. https://doi.org/10.3171/2013.3.JNS12766
Sicignano G, Losa M, del Vecchio A, Cattaneo GM, Picozzi P, Bolognesi A, Mortini P, Calandrino R (2012) Dosimetric factors associated with pituitary function after Gamma Knife Surgery (GKS) of pituitary adenomas. Radiother Oncol 104(1):119–124. https://doi.org/10.1016/j.radonc.2012.03.021
Ironside N, Chen CJ, Xu Z, Schlesinger D, Lee Vance M, Hong GK, Jane JA Jr, Patel S, Bindal SK, Niranjan A, Lunsford LD, Liscak R, Chytka T, Jezkova J, Saifi O, Trifiletti DM, Berger A, Alzate J, Bernstein K, Kondziolka D, Speckter H, Hernandez W, Lazo E, Peker S, Samanci Y, Zacharia BE, Mau C, Wegner RE, Shepard MJ, Mathieu D, Maillet M, Sheehan JP (2023) Effects of neuroanatomic structural distances on pituitary function after stereotactic radiosurgery: a multicenter study. Neurosurgery 92(5):1035–1042. https://doi.org/10.1227/neu.0000000000002347
Maione L, Li CY, Chanson P (2021) Endocrinological diagnosis and treatment of TSH-secreting pituitary adenomas. In: Honegger JB, Reincke M, Petersenn S (eds) Pituitary tumors: a comprehensive and interdisciplinary approach. Academic Press, London, pp 245–260
Losa M, Barzaghi LR, Albano L, Mortini P (2021) Pituitary adenomas: Radiosurgery. In: Honegger JB, Reincke M, Petersenn S (eds) Pituitary tumors: a comprehensive and interdisciplinary approach. Academic Press, London, pp 471–481
Funding
This research did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
L. Albano was a recipient of the Lars Leksell Gamma Knife Fellowship. The other authors declare that they have no conflicts of interest.
Ethical approval
This study was approved by the Ethics Committee of Istituto Scientifico San Raffaele, Milan, Italy.
Informed consent
Informed consent was waived for this retrospective, observational study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Losa, M., Albano, L., Barzaghi, L.R. et al. Gamma knife radiosurgery is effective in patients with thyrotropin-secreting pituitary adenomas. J Endocrinol Invest (2024). https://doi.org/10.1007/s40618-023-02291-1
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s40618-023-02291-1